Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Melrose Industries makes 'good start to the year' in Q1

(Sharecast News) - Aerospace manufacturer Melrose Industries said on Wednesday that it had made "a good start to the year", with Q1 revenue, profits and cash all in line with internal expectations. Melrose said group revenues were up 6% year-on-year, with strong progress in its engines division, up 9%, as well as in its structures division, up 4%.

As a result of its restructuring and business improvement actions, Melrose stated adjusted operating profits were "well ahead" of the same period last year, while net debt and free cash flow at the end of the quarter were in line with internal expectations.

The FTSE 100-listed firm added that it has a "path to successfully mitigate" its identified direct exposure to Donald Trump's recent "Liberation Day" tariffs, specifically the movement of products to customers in the US and the supply of products into its manufacturing sites.

Looking ahead, Melrose expects FY revenues to be between £3.55bn and £3.70bn, while adjusted operating profits were pegged to be roughly £700.0m. In line with historical and industry seasonality, profit and cash were expected to be second-half weighted, with negative free cash flow in the first half.

Chief executive Peter Dilnot said: "The recent introduction of tariffs has created additional complexity across the aerospace industry. We have acted swiftly to evaluate potential effects on the group and have a path to successfully mitigate our identified direct exposure at current tariff levels. The situation remains fluid, and we will continue to work closely with our customers and suppliers to respond as needed.

"Melrose has established positions on all the world's leading aircraft and underlying demand remains very strong in both our civil and defence markets. Our business improvements are reading through with more benefits to come going forwards. We are therefore confident about delivering profitable growth and significantly increasing free cash flow in 2025 and in the years ahead."

As of 0930 BST, Melrose shares were down 0.60% at 429.40p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.